Pharma Stock Pops After Receiving Approval From Health Canada (HC)

Pharma Stock Pops After Receiving Approval From Health Canada (HC)

By: Dylan Sikes – News

Monday, April 5, 2021

A Calgary-based pharmaceutical company turned heads today after they announced it received approval from Health Canada (HC) for its product, MultiX barium sulfate powder. Shares of Voyageur Pharmaceuticals Ltd. (TSX-V:VM) rallied on the news as this is the second license the company has received for MultiX.

Voyageur Pharmaceuticals Ltd. is engaged in the development of pharmaceutical ingredients (API) minerals. The company focuses on developing barium and iodine radiocontrast products and bromine based pharmaceutical products. It provides its products to medical applications and diagnostics.

Traders were optimistic on the news as shares hit a session high of $0.19/share (+8.57%) following the announcement. This move is welcomed by investors that have been holding this stock since making a multi-year high of $0.35 in February. 

Copyright © 2021 All rights reserved. Republication or redistribution of's content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Tech Stock Rallies On Two Purchase Orders Announcement
$1 Million In Purchase Orders Sends Industrial Micro-Cap Higher
Illinois School District Latest of Many To Sign Contract With This Company For School Bus Safety Technology
Most Popular
FREE Newsletter Favorites

Back to Top